Cigna CAO sells 899 shares after option exercise

Cigna Group Chief Accounting Officer Jamie G. Kates exercised employee stock options for 899 shares of common stock at $152.8947 per share and, on the same date, sold 899 shares in an open-market transaction at $298.612 per share.

Rhea-AI Filing Summary

Cigna Group Chief Accounting Officer Jamie G. Kates exercised employee stock options for 899 shares of common stock at $152.8947 per share and, on the same date, sold 899 shares in an open-market transaction at $298.612 per share. Following these transactions, Kates directly holds 2,368 Cigna common shares. The exercised option was originally granted on February 28, 2018 and vested in three equal annual installments beginning February 28, 2019.

Insider Trade Summary

Exercise and Sale: 899 shares ($131K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Kates Jamie G

Role Chief Accounting Officer

Sold 899 shs ($268K)

Approx. gross sale proceeds $268K

Approx. exercise cost $137K

Approx. pre-tax spread $131K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	899	$0.00	$0.00
Exercise	Common Stock, $.01 Par Value	899	$152.8947	$137K
Sale	Common Stock, $.01 Par Value	899	$298.612	$268K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock, $.01 Par Value — 2,368 shares (Direct)

Footnotes (1)

1. F1. This option was granted on February 28, 2018. The option vested in three equal annual installments starting on February 28, 2019.

Key Figures

Shares sold: 899 shares Sale price: $298.612 per share Options exercised: 899 shares +4 more

7 metrics

Shares sold 899 shares Open-market sale of common stock on June 12, 2026

Sale price $298.612 per share Average price for 899 common shares sold

Options exercised 899 shares Employee Stock Option converted into common stock

Option exercise price $152.8947 per share Conversion or exercise price of Employee Stock Option

Shares held after 2,368 shares Direct Cigna common stock holdings post-transaction

Option grant date February 28, 2018 Grant date of exercised Employee Stock Option

Option expiration March 7, 2028 Expiration date of the Employee Stock Option

Key Terms

open-market sale, Employee Stock Option (Right to Buy), Exercise or conversion of derivative security, Chief Accounting Officer, +1 more

5 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Employee Stock Option (Right to Buy) financial

"security_title": "Employee Stock Option (Right to Buy)""

Exercise or conversion of derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

Chief Accounting Officer financial

"officer_title": "Chief Accounting Officer""

A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.

derivative security financial

"transaction_type": "derivative""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cigna (CI) report for Jamie G. Kates?

Cigna reported that Chief Accounting Officer Jamie G. Kates exercised employee stock options for 899 common shares and sold 899 common shares in an open-market transaction on June 12, 2026, according to a Form 4 insider trading disclosure.

At what prices did Jamie G. Kates exercise and sell Cigna (CI) shares?

Jamie G. Kates exercised employee stock options at a strike price of $152.8947 per Cigna share and sold 899 common shares at an average price of $298.612 per share in an open-market sale on June 12, 2026.

How many Cigna (CI) shares does Jamie G. Kates hold after this Form 4?

After the reported option exercise and open-market sale, Jamie G. Kates directly holds 2,368 shares of Cigna common stock, as stated in the Form 4’s post-transaction ownership column for the non-derivative common stock holdings.

What employee stock option grant did Jamie G. Kates exercise at Cigna (CI)?

Jamie G. Kates exercised an Employee Stock Option covering 899 Cigna common shares with a conversion or exercise price of $152.8947 per share. The option was granted on February 28, 2018 and vested in three equal annual installments starting February 28, 2019.

Does Jamie G. Kates have remaining employee stock options in this Cigna (CI) filing?

In this Form 4, the derivative section shows an Employee Stock Option for 899 shares exercised down to zero remaining, and the derivative summary is empty, indicating no remaining derivative positions are reported in this particular filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 05:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kates Jamie G

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CONNECTICUT 06002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	06/12/2026		M		899	A	$152.8947	3,267	D
Common Stock, $.01 Par Value	06/12/2026		S		899	D	$298.612	2,368	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$152.8947	06/12/2026		M			899	02/28/2019(1)	03/07/2028	Common Stock, $.01 Par Value	899	$0	0	D

Explanation of Responses:

1. This option was granted on February 28, 2018. The option vested in three equal annual installments starting on February 28, 2019.

Remarks:

	Tyler Gratton, attorney-in-fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)